Dr Morgane Brunton - O'Sullivan
Research Officer
Working groups
Background
Morgane completed her PhD titled 'Extracellular matrix biomarkers in acute myocardial infarction' in 2022 at the University of Otago, New Zealand. She joined the Infection, Inflammation and Innate Immunity group at Burnet in 2023 and applied her expertise in cardiovascular disease to the context infectious disease. In this role, she is specifically interested in understanding how chronic inflammation and immune cell dysfunction contribute to comorbidities in people living with HIV and inflammation-driven diseases. Specifically, her research has focused on biological mechanisms driving frailty and cardiovascular disease. Morgane is a translational researcher with key lab skills in cell culture, flow cytometry and fluorescence microscopy.
Qualifications
- 2018–2022: Doctor of Philosophy (PhD), University of Otago, New Zealand
- 2013–2016: Bachelor of Biomedical Science (First Class Honours), Victoria University of Wellington, New Zealand
Burnet publications
Afucosylated broadly neutralizing antibodies targeting the HIV envelope elicit enhanced NK-cell–mediated cytotoxicity against HIV-infected CD4+ T-cell and macrophage targets
Journal of Leukocyte Biology
Olaf G. Wilhelm et al
Linking Neutrophil Extracellular Traps and Platelet Activation: A Composite Biomarker Score for Predicting Outcomes after Acute Myocardial Infarction
Thrombosis and Haemostasis
Morgane M. Brunton-O’Sullivan
An IL-6-IL-8 score derived from principal component analysis is predictive of adverse outcome in acute myocardial infarction
Cytokine X
Morgane M. Brunton-O’Sullivan
